Get started
Author

Maria Benkhadra

Observed name: M. Benkhadra
ORCID: 0000-0002-2382-3021
Observed ORCID: 0000-0002-2382-3021
OpenAlex ID: A5043087076
An Interventional Call-Back Service to Improve Appropriate Use of Antibiotics in Community Pharmacies
2021 · Bridget Paravattil, Monica Zolezzi, et al. · Antibiotics · 9
PDF
Caught in the Crossfire: Unmasking the Silent Renal Threats of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
2024 · Maria Benkhadra, Rola Ghasoub, et al. · Cancers · 8
PDF
Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials
2023 · Fateen Ata, Maria Benkhadra, et al. · Frontiers in Oncology · 8
PDF
Male Fertility and Fatherhood in Chronic Myeloid Leukemia: Current Understanding and Future Perspectives
2024 · Ahmed Adel Elsabagh, Maria Benkhadra, et al. · Cancers · 6
PDF
Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study)
2025 · Nabil E. Omar, Shereen Elazzazy, et al. · Frontiers in Immunology · 5
PDF
Carfilzomib-induced life-threatening lung injury in refractory multiple myeloma
2023 · Rola Ghasoub, Maria Benkhadra, et al. · Journal of Oncology Pharmacy Practice · 5
A deep dive into the surgical and pharmacological considerations of obesity in chronic myeloid leukemia: a narrative review
2025 · Rola Ghasoub, Basant Elsayed, et al. · Frontiers in Oncology · 4
PDF
The Safety of Novel Therapies in Chronic Lymphocytic Leukemia in the Era of Intermittent Fasting: A Pharmacology-Based Review
2024 · Maria Benkhadra, Nuha Fituri, et al. · Cancers · 4
PDF
Pregnancy in women with myelodysplastic syndromes: a scoping review of maternal, obstetric, and neonatal outcomes
2026 · Shehab F. Mohamed, Fadel Alqatati, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2
PDF
Evaluating the Safety of Combining Tyrosine Kinase Inhibitors with Anticoagulants in Chronic Myeloid Leukemia: A Systematic Review
2026 · Amna Gameil, Rola Ghasoub, et al. · Oncology · 2
PDF
Chronic Lymphocytic Leukemia in Pregnancy: A Review of the Available Literature and the Pharmacological Challenges in Management
2024 · Ahmed Badr, Maria Benkhadra, et al. · Oncology · 2
Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review
2024 · Hesham Elsabah, Rola Ghasoub, et al. · Frontiers in Oncology · 2
PDF
Establishment of a Clinical Pharmacist-Led Multiple Myeloma Clinic with Collaborative Prescribing Model at the National Center for Cancer Care and Research in Qatar
2023 · Rola Ghasoub, Shereen Elazzazy, et al. · Blood · 2
Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar
2023 · Maria Benkhadra, Shereen Elazzazy, et al. · Blood · 2
Impact of Tyrosine Kinase Inhibitors on Estimated Glomerular Filtration Rate in Chronic Myeloid Leukemia Patients
2026 · Awni Alshurafa, Maria Benkhadra, et al. · Oncology · 1
PDF
Contraception in Myeloproliferative Neoplasms: A Pharmacological Review
2025 · Awni Alshurafa, Maria Benkhadra, et al. · European Journal Of Haematology · 1
PDF
577P A real-world analysis of immune checkpoint inhibitors outcomes in patients with baseline auto-immune diseases
2024 · N.E. Omar, H. Elewa, et al. · Annals of Oncology · 1
571P The economic sequelae of immune related adverse events secondary to immune checkpoints inhibitors in Qatar: A hospital-perspective analysis
2024 · N.E. Omar, L.K. Shafei, et al. · Annals of Oncology · 1
Renal Adverse Events in Chronic Myeloid Leukemia: Can the Exposure to One TKI be the Culprit?
2024 · Reem Hajeomar, Maria Benkhadra, et al. · Blood · 1
Evaluating the Safety of Combining Tyrosine Kinase Inhibitors with Anticoagulants in Chronic Myeloid Leukemia : A Systematic Review
2024 · Amna Gameil, Rola Ghasoub, et al. · Blood · 1
A Comparison of Different Venous Thromboembolism Prediction Scoring Systems in Newly Diagnosed Multiple Myeloma in an Arabic Population
2024 · Ghasoub Rola, Hesham Elsabah, et al. · Blood · 1
PDF
Establishment of a clinical pharmacist-led multiple myeloma clinic with collaborative prescribing model at the national center for cancer care and research in Qatar
2024 · Rola Ghasoub, Shereen Elazzazy, et al. · Journal of the American Pharmacists Association · 1
Precision medicine in acute lymphoblastic leukemia: A narrative review of current strategies and future directions
2026 · Sondus Jawad, Maria Benkhadra, et al. · Therapeutic Advances in Hematology
Correction: Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study)
2026 · Nabil E. Omar, Shereen Elazzazy, et al. · Frontiers in Immunology
PDF
Transforming Acute Myeloid Leukemia Care through Precision Medicine: Integrating Genomic Profiling, Measurable Residual Disease, and Targeted Therapies
2026 · Rafal Al-Shibly, Maria Benkhadra, et al. · Oncology
Works count: 36
Citation count: 69
H-index: 5
I10-index:
Year
Topic
Type